UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition DZPorifarm-5mg-Solution-SE-IS-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-100002342-00057369, http://ema.europa.eu/fhir/eurdId
/1029
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Tablet
indication:
Diazepam påverkar de vid ångestsyndrom vanliga symtomen ängslan, ångest, rastlöshet och därav följande sömnsvårigheter. Vid depressioner med inslag av nämnda symtom kan Diazepam Orifarm ges i kombination med antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom i samband med alkoholmissbruk. Cerebralt och perifert betingade muskelspasmer. Premedicinering.
legalStatusOfSupply: Medicinal product subject to special medical prescription
classification: N05BA01
name
productName: Diazepam Orifarm 5 mg Tablett
part
part: Diazepam Orifarm
type: Invented name part
part
part: 5 mg
type: Strength part
part
part: Tablett
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish